Raziky, M. E., Hamdy, S., Hamada, Y., Abdelaziz, N. M., Hassany, M., Doss, W., & Zakaria, Z. (2022). Efficacy and safety of sofosbuvir and daclatasvir in patients with chronic hepatitis C virus induced cirrhosis with Child-Pugh class B. SpringerOpen.
Chicago Style (17th ed.) CitationRaziky, Mayssa El, Sherif Hamdy, Yasser Hamada, Nermin Mohamed Abdelaziz, Mohamed Hassany, Wahid Doss, and Zeinab Zakaria. Efficacy and Safety of Sofosbuvir and Daclatasvir in Patients with Chronic Hepatitis C Virus Induced Cirrhosis with Child-Pugh Class B. SpringerOpen, 2022.
MLA (9th ed.) CitationRaziky, Mayssa El, et al. Efficacy and Safety of Sofosbuvir and Daclatasvir in Patients with Chronic Hepatitis C Virus Induced Cirrhosis with Child-Pugh Class B. SpringerOpen, 2022.
Warning: These citations may not always be 100% accurate.